EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tackling schistosomiasis in fisherfolk communities in Uganda: Enablers and challenges for implementing paediatric schistosomiasis mass drug administration from the perspective of district health authorities

Lisa Sophie Reigl, Isabelle L Lange, Orkan Okan, Stella Neema, Andrea S Winkler

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · 2025

DOI: 10.1007/s00103-025-04066-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2025. Verfasst von Lisa Sophie Reigl und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, TUM University Hospital and Center for Global Health, School of Medicine and Health, Technical University of Munich, Munich,…. Hauptthemen laut MEDLINE: Mass Drug Administration, Schistosomiasis, Praziquantel. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Technische Universität München.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Schistosomiasis remains a significant public health issue in Uganda, particularly among fishing communities. This study, nested within a larger community-based study (ADOPT) on introducing a new child-friendly praziquantel formulation for schistosomiasis, arpraziquantel, explored enablers and challenges perceived by district health authorities for implementing a mass drug administration (MDA) programme with arpraziquantel.

Methods

Respondents in this cross-sectional study were purposively selected in Bugiri and Hoima districts, Uganda. Key informant interviews were conducted in July 2022 and thematically analysed using the World Health Organization health system building blocks framework.

Results

In general, arpraziquantel is expected to be widely accepted, though some may oppose it for religious or political reasons, belief in witchcraft as a cause of schistosomiasis, or fear of side effects. High awareness of disease burden and the acceptance of the existing schistosomiasis MDA for adults and school-aged children were identified as enablers for successful implementation. Key implementation challenges include limited resources for sustained biannual MDAs, adequate remuneration of village health teams (VHTs), inadequate staff training, time constraints, uneven VHT workload, and weaknesses in the referral systems. Migration, difficulties sensitising mobile parents, and delayed meals due to poverty—complicating drug absorption requiring a full stomach—further hinder efforts.

Discussion

This study underscores the importance of addressing health systems’ challenges through targeted measures to ensure effective and sustainable MDA of arpraziquantel, including enhanced training of VHTs and other staff, sensitisation of parents and key stakeholders at all levels, and adequate responses to potentially emerging side effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mass Drug AdministrationSchistosomiasisPraziquantelHumansUgandaCross-Sectional StudiesChildFemaleMaleAdultAdolescentChild, PreschoolAnthelmintics

Stichwörter der Autor:innen

ArpraziquantelDistrict health authoritiesMass drug administrationPreschool-aged childrenSchistosomiasis

Substanzen

PraziquantelAnthelmintics

Autor:innen und Institutionen

  • Department of Neurology, TUM University Hospital and Center for Global Health, School of Medicine and Health, Technical University of Munich, Munich, Germany.
  • Department of Infectious Disease Epidemiology and International Health, London School of Hygiene & Tropical Medicine, London, UK.
  • Health Literacy Unit, Department of Health and Sport Sciences, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.
  • WHO Collaborating Centre for Health Literacy, Department of Health and Sport Sciences, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.
  • Department of Sociology and Anthropology, Makerere University, Kampala, Uganda.
  • Department of Neurology, TUM University Hospital and Center for Global Health, School of Medicine and Health, Technical University of Munich, Munich, Germany. andrea.winkler@tum.de.

Förderung

  • Technische Universität München

Zitieren

APA

Reigl, L. S., Lange, I. L., Okan, O., Neema, S., & Winkler, A. S. (2025). Tackling schistosomiasis in fisherfolk communities in Uganda: Enablers and challenges for implementing paediatric schistosomiasis mass drug administration from the perspective of district health authorities. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. https://doi.org/10.1007/s00103-025-04066-w

Vancouver

Reigl LS, Lange IL, Okan O, Neema S, Winkler AS. Tackling schistosomiasis in fisherfolk communities in Uganda: Enablers and challenges for implementing paediatric schistosomiasis mass drug administration from the perspective of district health authorities. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 2025. doi:10.1007/s00103-025-04066-w

BibTeX
@article{Reigl2025,
  author = {Reigl, Lisa Sophie and Lange, Isabelle L and Okan, Orkan and Neema, Stella and Winkler, Andrea S},
  title = {Tackling schistosomiasis in fisherfolk communities in Uganda: Enablers and challenges for implementing paediatric schistosomiasis mass drug administration from the perspective of district health authorities},
  journal = {Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz},
  year = {2025},
  doi = {10.1007/s00103-025-04066-w}
}
Kostenlos starten →